Literature DB >> 12437073

Bruton's tyrosine kinase is activated upon CD40 stimulation in human B lymphocytes.

Cornelia Brunner1, Andris Avots, Hans Wolfgang Kreth, Edgar Serfling, Volker Schuster.   

Abstract

Bruton's tyrosine kinase (Btk) is known to be involved in a broad array of signal transduction pathways necessary for the proliferation, survival and development of B cells. Mutations in the Btk gene are causually linked to the development of X-linked agammaglobulinemia (XLA) in humans. We show here, that CD40 ligation leads to tyrosine phosphorylation of Btk in the human immature B cell line MHH-PREB-1. Even though the CD40-mediated tyrosine phosphorylation of Btk is less efficient than that mediated through the B cell receptor, CD40 stimulation results in a marked and continous activation of Btk in MHH-PREB-1 cells and, to a lesser extent, in a transient Btk activation in Daudi cells. Furthermore, in Daudi cells we observed that tyrosine phosphorylation and activation of Btk is correlated with its translocation from the cytosolic to the membraneous fraction. These data suggest that, in addition to the BCR, CD40 is a surface receptor through which the activity of Btk can be stimulated in human B cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12437073     DOI: 10.1078/0171-2985-00192

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  8 in total

1.  Ibrutinib treatment improves T cell number and function in CLL patients.

Authors:  Meixiao Long; Kyle Beckwith; Priscilla Do; Bethany L Mundy; Amber Gordon; Amy M Lehman; Kami J Maddocks; Carolyn Cheney; Jeffrey A Jones; Joseph M Flynn; Leslie A Andritsos; Farrukh Awan; Joseph A Fraietta; Carl H June; Marcela V Maus; Jennifer A Woyach; Michael A Caligiuri; Amy J Johnson; Natarajan Muthusamy; John C Byrd
Journal:  J Clin Invest       Date:  2017-07-17       Impact factor: 14.808

2.  Intracellular MHC class II molecules promote TLR-triggered innate immune responses by maintaining activation of the kinase Btk.

Authors:  Xingguang Liu; Zhenzhen Zhan; Dong Li; Li Xu; Feng Ma; Peng Zhang; Hangping Yao; Xuetao Cao
Journal:  Nat Immunol       Date:  2011-03-27       Impact factor: 25.606

3.  TLR-induced activation of Btk -- role for endosomal MHC class II molecules revealed.

Authors:  Joan Ní Gabhann; Caroline A Jefferies
Journal:  Cell Res       Date:  2011-05-24       Impact factor: 25.617

4.  The splenic marginal zone shapes the phenotype of leukemia B cells and facilitates their niche-specific retention and survival.

Authors:  Vanessa Stache; Lydia Verlaat; Marcel Gätjen; Kristina Heinig; Jörg Westermann; Armin Rehm; Uta E Höpken
Journal:  Oncoimmunology       Date:  2017-05-02       Impact factor: 8.110

5.  BTK signaling drives CD1dhiCD5+ regulatory B-cell differentiation to promote pancreatic carcinogenesis.

Authors:  Shipra Das; Dafna Bar-Sagi
Journal:  Oncogene       Date:  2019-01-11       Impact factor: 9.867

Review 6.  Targeting Bruton's Tyrosine Kinase in Inflammatory and Autoimmune Pathologies.

Authors:  Stefan F H Neys; Rudi W Hendriks; Odilia B J Corneth
Journal:  Front Cell Dev Biol       Date:  2021-06-04

7.  Pre-clinical anti-tumor activity of Bruton's Tyrosine Kinase inhibitor in Hodgkin's Lymphoma cellular and subcutaneous tumor model.

Authors:  Irfana Muqbil; Mahmoud Chaker; Amro Aboukameel; Ramzi M Mohammad; Asfar S Azmi; Radhakrishanan Ramchandren
Journal:  Heliyon       Date:  2019-08-31

8.  Pre-clinical blocking of PD-L1 molecule, which expression is down regulated by NF-κB, JAK1/JAK2 and BTK inhibitors, induces regression of activated B-cell lymphoma.

Authors:  Christelle Vincent-Fabert; Lilian Roland; Ursula Zimber-Strobl; Jean Feuillard; Nathalie Faumont
Journal:  Cell Commun Signal       Date:  2019-08-05       Impact factor: 5.712

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.